Torrent Pharma Raises ₹300 Cr via Commercial Papers—Boosts Liquidity with 90-Day Issue

Torrent Pharmaceuticals Ltd. has issued ₹300 crore worth of unsecured commercial papers (CPs) on March 25, 2025, as part of its short-term funding strategy to manage working capital and operational needs. The CPs carry a discount rate of 7.13% per annum and will mature on June 23, 2025, according to a regulatory filing.

 

These instruments, tradable on the National Stock Exchange (NSE), are issued at a discount and will be redeemed at face value upon maturity. Torrent Pharma emphasized that there have been no defaults or delays in its debt obligations, reinforcing its strong credit profile. The move aligns with the company’s broader financial strategy to maintain liquidity efficiency amid dynamic market conditions.

 

On the day of issuance, Torrent Pharma’s stock closed 0.60% higher at ₹3,279.30, reflecting investor confidence. The company’s shares have seen a 52-week high of ₹3,589.95 and a low of ₹2,508.65.

 

Key Highlights:

Source: Angel One